Nucleic Acids as Molecular Diagnostics.

By integrating technology, supporting infrastructure and efficient application, this all-in-one guide presents molecular diagnostics as an essential component of modern, personalized clinical practice. It considers all important aspects, from the hardware and software needed, to recent improvements...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Keller, Andreas
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Wiley-VCH, 2014.
Temas:
Nucleic acids.
Nucleic acids
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Ma 4500
001 EBOOKCENTRAL_ocn890441752
003 OCoLC
005 20240329122006.0
006 m o d
007 cr |n|||||||||
008 140912s2014 xx o 000 0 eng d
040 |a IDEBK  |b eng  |e pn  |c IDEBK  |d EBLCP  |d CDX  |d COO  |d OCLCO  |d RECBK  |d OCLCF  |d OCLCQ  |d DEBSZ  |d OCLCQ  |d ZCU  |d MERUC  |d OCLCQ  |d ICG  |d OCLCQ  |d DKC  |d OCLCQ  |d OCLCO  |d SGP  |d OCLCQ  |d OCLCO  |d OCLCL 
020 |a 1322110638  |q (ebk) 
020 |a 9781322110639  |q (ebk) 
020 |a 9783527672233 
020 |a 3527672230 
020 |a 9783527672226 
020 |a 3527672222 
020 |a 9783527672219 
020 |a 3527672214 
020 |a 9783527672165 
020 |a 3527672168 
020 |a 9783527335565 
020 |a 3527335560 
029 1 |a AU@  |b 000061137192 
029 1 |a DEBBG  |b BV043891740 
029 1 |a DEBSZ  |b 431764409 
029 1 |a DEBSZ  |b 449448940 
035 |a (OCoLC)890441752 
037 |a 642314  |b MIL 
050 4 |a RB43.8.N83 
082 0 4 |a 616.1  |2 23 
049 |a UAMI 
100 1 |a Keller, Andreas. 
245 1 0 |a Nucleic Acids as Molecular Diagnostics. 
260 |b Wiley-VCH,  |c 2014. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 0 |a Print version record. 
505 0 |a Nucleic Acids as Molecular Diagnostics; Contents; List of Contributors; Preface; 1 Next-Generation Sequencing for Clinical Diagnostics of Cardiomyopathies; 1.1 Introduction; 1.2 Cardiomyopathies and Why Genetic Testing is Needed; 1.3 NGS; 1.4 NGS for Cardiomyopathies; 1.5 Sample Preparation; 1.6 Bioinformatics Analysis Pipeline; 1.7 Interpretation of Results and Translation into Clinical Practice; References; 2 MicroRNAs as Novel Biomarkers in Cardiovascular Medicine; 2.1 Introduction; 2.2 miRNAs are Associated with Cardiovascular Risk Factors; 2.3 miRNAs in Coronary Artery Disease 
505 8 |a 2.4 miRNAs in Cardiac Ischemia and Necrosis2.5 miRNAs as Biomarkers of Heart Failure; 2.6 Future Challenges; Acknowledgments; References; 3 MicroRNAs in Primary Brain Tumors: Functional Impact and Potential Use for Diagnostic Purposes; 3.1 Background; 3.2 Gliomas; 3.2.1 miRNA as Biomarkers in Glioma Tissue; 3.2.2 Circulating miRNA as Biomarkers; 3.3 Meningiomas; 3.4 Pituitary Adenomas; 3.5 Medulloblastomas; 3.6 Other Brain Tumors; 3.6.1 Schwannomas; 3.6.2 PCNSLs; 3.7 Summary and Outlook; References; 4 Genetic and Epigenetic Alterations in Sporadic Colorectal Cancer: Clinical Implications 
505 8 |a 4.1 Introduction4.2 Chromosomal Instability; 4.3 Microsatellite Instability; 4.4 Driver Somatic Mutations in CRC; 4.4.1 APC; 4.4.2 TP53; 4.4.3 KRAS; 4.4.4 BRAF; 4.4.5 PIK3CA; 4.4.6 Other Mutations; 4.5 Epigenetic Instability in CRC; 4.6 Hypomethylation; 4.7 CpG Island Methylator Phenotype; 4.8 Concluding Remarks; References; 5 Nucleic Acid-Based Markers in Urologic Malignancies; 5.1 Introduction; 5.2 Bladder Cancer; 5.2.1 Hereditary Factors for Bladder Cancer; 5.2.2 Single Nucleotide Polymorphisms; 5.2.3 RNA Alterations in Bladder Cancer; 5.2.3.1 FGFR3 Pathway; 5.2.3.2 p53 Pathway 
505 8 |a 5.2.3.3 Urine-Based Markers5.2.3.4 Serum-Based Markers; 5.2.4 Sporadic Factors for Bladder Cancer; 5.2.5 Genetic Changes in Non-Invasive Papillary Urothelial Carcinoma; 5.2.5.1 FGFR 3; 5.2.5.2 Changes in the Phosphatidylinositol 3-Kinase Pathway; 5.2.6 Genetic Changes in Muscle-Invasive Urothelial Carcinoma; 5.2.6.1 TP53, RB, and Cell Cycle Control Genes; 5.2.6.2 Other Genomic Alterations; 5.2.7 Genetic Alterations with Unrecognized Associations to Tumor Stage and Grade; 5.2.7.1 Alterations of Chromosome 9; 5.2.7.2 RAS Gene Mutations; 5.3 Prostate Cancer 
505 8 |a 5.3.1 Hereditary Factors for Prostate Cancer5.3.2 Sporadic Factors for Prostate Cancer; 5.3.2.1 PSA and Other Protein Markers; 5.3.2.2 Nucleic Acid Biomarkers; 5.3.3 Prostate Cancer: Summary; 5.4 Renal Cell Carcinoma; 5.4.1 Hereditary Factors for RCC; 5.4.2 Sporadic Factors for RCC; 5.4.2.1 The Old; 5.4.2.2 The New; 5.5 Summary; References; 6 From the Genetic Make-Up to the Molecular Signature of Non-Coding RNA in Breast Cancer; 6.1 Introduction; 6.2 Molecular Breast Cancer Detection; 6.2.1 Circulating Free DNA; 6.2.2 Long Intergenic Non-Coding RNA; 6.2.2.1 HOTAIR; 6.2.2.2 H19; 6.2.2.3 GAS5 
520 |a By integrating technology, supporting infrastructure and efficient application, this all-in-one guide presents molecular diagnostics as an essential component of modern, personalized clinical practice. It considers all important aspects, from the hardware and software needed, to recent improvements in blood- and non-blood-based biomarker tests. Chapters on ethical challenges and a look at current trends and the latest innovations are also included.Bridging the gap between industry and academia, this is a highly useful resource for practitioners as well as for developers of modern, DNA- and RNA. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Nucleic acids. 
650 7 |a Nucleic acids  |2 fast 
758 |i has work:  |a Nucleic acids as molecular diagnostics (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCFvGT9R4Dy343XRTMRYbbb  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |z 9781322110639 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1780451  |z Texto completo 
938 |a Coutts Information Services  |b COUT  |n 29772344 
938 |a EBL - Ebook Library  |b EBLB  |n EBL1780451 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n cis29772344 
938 |a Recorded Books, LLC  |b RECE  |n rbeEB00596195 
994 |a 92  |b IZTAP 

Ejemplares similares